Target prices for mass production of tyrosine kinase inhibitors for global cancer treatment

OBJECTIVE: To calculate sustainable generic prices for 4 tyrosine kinase inhibitors (TKIs). BACKGROUND: TKIs have proven survival benefits in the treatment of several cancers, including chronic myeloid leukaemia, breast, liver, renal and lung cancer. However, current high prices are a barrier to tre...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMJ Open
Autors principals: Hill, Andrew, Gotham, Dzintars, Fortunak, Joseph, Meldrum, Jonathan, Erbacher, Isabelle, Martin, Manuel, Shoman, Haitham, Levi, Jacob, Powderly, William G, Bower, Mark
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2016
Matèries:
Global Health
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4735306/
https://ncbi.nlm.nih.gov/pubmed/26817636
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2015-009586
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars